Phathom Pharmaceuticals Inc

NASDAQ:PHAT   3:46:32 PM EDT
29.33
-0.17 (-0.58%)
Earnings Announcements

Phathom Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/30/2021 20:31 GMT
Phathom Pharmaceuticals Inc (PHAT) - Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress.
Phathom Pharmaceuticals Inc - Qtrly Loss per Share $1.58.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.99

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.10

More details on our Analysts Page.